Oncopole proudly announces the support of three new partners to help fund its first competition, EMC2 (Results to be published in June). This competition objective is to fund federative research projects to build on Quebec’s expertise and strengths in the field of oncology.
From the outset, CQDM will provide up to 40% of the budget for projects jointly selected with Oncopole that respond to their SynergiQc program criteria, while IRICoR will support drug discovery projects within their investment criteria. For genomics-related projects, Génome Québec will likewise provide substantial financial support up to $2M.
These funds will be combined to $1.5M already committed by the Cancer Research Society last February, which brings the total envelope for the EMC2 competition up to $11M in grants. These significant contributions represent a decisive landmark where these leading organizations recognize the value of the unique model put forward by Oncopole.
With the creation of an attractive collaborative hub for researchers and funding organizations, Oncopole is achieving its goal of uniting key players in the field of oncology and fulfilling its mission to make Quebec a centre of excellence in the fight against cancer.
